Floatz logo

pds01adc

Anal Carcinoma

National Cancer Institute (NCI)Phase 1/2Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
73/ 100

Competitive context

45 Active assets in the Anal Carcinoma cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
Federation Francophone de Cancerologie Digestive
Phase 3BB
Carboplatin
Dustin Deming
Phase 3BB
Nivolumab
Instituto do Cancer do Estado de São Paulo
Phase 3BB
Irinotecan
University of Cincinnati
Phase 3BB
CIS-DIAMMINEDICHLOROPLATINUM II
Federation Francophone de Cancerologie Digestive
Phase 3BB

View all 50 →

Same molecule, other indications

pds01adc is also rated in:

prostate carcinomaDormant
B
Indicative ·
60 / 100
View asset →
intrahepatic bile duct cancerDormant
CCC
Indicative ·
53 / 100
View asset →
colorectal cancerDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →